Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank13
3Y CAGR-15.1%
5Y CAGR-9.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-15.1%/yr
vs -9.7%/yr prior
5Y CAGR
-9.5%/yr
Recent deceleration
Acceleration
-5.4pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $20.99M | -42.4% |
| 2024 | $36.44M | -35.2% |
| 2023 | $56.22M | +63.8% |
| 2022 | $34.31M | -47.8% |
| 2021 | $65.80M | +90.1% |
| 2020 | $34.60M | -77.6% |
| 2019 | $154.67M | +199.4% |
| 2018 | $51.66M | +555.8% |
| 2017 | $7.88M | - |